Stock Screener App
Frei
-
Play Store
App Store
Installieren
Installieren
Light
Dark
DE
anmelden
Beobachtungsliste
Top-Listen
Märkte
Neu
Charts
Kryptos
Branchen
Elite
Marktsimulator
Produkte
RNA
$7.00
5.35%
0.355
Atrium Therapeutics Inc (RNA)
Indikator
5
EX
1min
5min
Hourly
Daily
Weekly
Monthly
Line
Candle
Vollbild-Chart
Überblick
Preisverlauf
Optionskette
Finanzen
Forum
Prognose
Finanzdaten der Atrium Therapeutics Inc-Aktie (RNA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums
2026-09-30
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Periodenlänge
3 Monate
3 Monate
3 Monate
3 Monate
3 Monate
Revenues
410.02%
15.32
3.00
19.64
0.86
12.48
Operating Expenses
14.33%
21.95
25.62
36.92
255.34
201.28
Research and Development
10.08%
13.80
15.34
16.66
166.60
154.95
Operating Income/Loss
70.69%
-6.63
-22.62
-17.28
-254.48
-188.81
Nonoperating Income/Loss
2.84%
2.36
2.43
0.65
17.38
14.36
Income/Loss From Continuing Operations Before Tax
-4.27
-
-
-237.10
12.48
Income Tax Expense/Benefit
-
-
-
-
-
Net Income/Loss
78.87%
-4.27
-20.19
-16.63
-237.10
-174.44
Attributable To Parent
78.87%
-4.27
-20.19
-16.63
-237.10
-174.44
Basic Average Shares
0.40%
17.04
17.11
17.11
5.43
137.90
Diluted Average Shares
0.40%
17.04
17.11
17.11
5.43
137.90
Basic Earnings Per Share
78.81%
-0.25
-1.18
-0.97
-1.59
-1.27
Diluted Earnings Per Share
78.81%
-0.25
-1.18
-0.97
-1.59
-1.27
Ähnlich wie RNA
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
In EDGAR öffnen
|
In Reuters öffnen